Articles related to DEPRESSION

Recent findings indicate a significant association between SSRI use in children and delayed puberty, with an odds ratio of 1.44. This underscores the importance of considering potential developmental impacts when prescribing these medications.

A Phase 2B study found that a 25mg dose of psilocybin, combined with psychotherapy, produced a significant drop in patients’ scores on the Montgomery Asberg Depression Rating Scale (MADRS) after 12 weeks. This finding underscores the potential of psilocybin-assisted therapy as a promising treatment for depression.

Despite the potential benefits of ketamine in treating a range of neurological and psychiatric disorders, the FDA has issued warnings about the potential risks associated with its use, emphasizing the need for careful prescription and clinical oversight.

The study suggests that approximately one heated yoga session per week was associated with significantly greater reduction in depression symptoms than a waitlist control. This finding indicates that heated yoga could be a viable non-medication-based treatment option for patients with moderate-to-severe depression.

In a recent study, researchers have discovered that gamma delta T cells in our intestines can influence our gut microbiome. This influence may extend to our brain functions and potentially impact stress-induced disorders such as depression.

With more than 5,000 patients studied in clinical trials, Exxua has demonstrated effectiveness for relieving depressive symptoms with an acceptable side effect profile.